| Q36835063 | Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse |
| Q40448817 | Aberrant DNA methylation associated with silencing BNIP3 gene expression in haematopoietic tumours. |
| Q79897814 | Aberrant DNA methylation of the Src kinase Hck, but not of Lyn, in Philadelphia chromosome negative acute lymphocytic leukemia |
| Q45355262 | Aberrant EPHB4 gene methylation and childhood acute lymphoblastic leukemia |
| Q39402662 | Aberrant methylation and decreased expression of the RIZ1 gene are frequent in adult acute lymphoblastic leukemia of T-cell phenotype |
| Q82539025 | Accumulation of DNA methylation is associated with tumor stage in gastric cancer |
| Q36497421 | Adverse prognostic impact of CDKN2B hyper-methylation in acute promyelocytic leukemia |
| Q37683456 | Age-related epigenetic drift in the pathogenesis of MDS and AML. |
| Q42140813 | Alternative mechanisms associated with silencing of CDKN1C in Beckwith-Wiedemann syndrome |
| Q37920890 | Cell cycle regulatory molecular profiles of pediatric T-cell lymphoblastic leukemia and lymphoma |
| Q35830464 | Characterization, tissue expression, and imprinting analysis of the porcine CDKN1C and NAP1L4 genes |
| Q36393321 | Correlation between CpG methylation profiles and hormone receptor status in breast cancers |
| Q35594048 | DNA methylation in haematological malignancies: the role of decitabine |
| Q39094566 | DNA methylation of membrane-bound tyrosine phosphatase genes in acute lymphoblastic leukaemia. |
| Q33628772 | DNA methylation predicts survival and response to therapy in patients with myelodysplastic syndromes |
| Q48402900 | DNAse I pre-treatment markedly enhances detection of nuclear cyclin-dependent kinase inhibitor p57Kip2 and BrdU double immunostaining in embryonic rat brain |
| Q40238946 | Differential tumor suppressor properties and transforming growth factor-beta responsiveness of p57KIP2 in leukemia cells with aberrant p57KIP2 promoter DNA methylation |
| Q36670000 | Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray |
| Q37324449 | Downregulation of JUNB mRNA expression in advanced phase chronic myelogenous leukemia |
| Q35916788 | Epigenetic inactivation of tumor suppressor genes in hematologic malignancies |
| Q37355967 | Epigenetics of acute lymphocytic leukemia |
| Q35020435 | Estrogen-mediated epigenetic repression of the imprinted gene cyclin-dependent kinase inhibitor 1C in breast cancer cells |
| Q34768789 | Evolution of decitabine development: accomplishments, ongoing investigations, and future strategies |
| Q52721971 | Genetic and Epigenetic Control of CDKN1C Expression: Importance in Cell Commitment and Differentiation, Tissue Homeostasis and Human Diseases. |
| Q35878552 | Genome-wide DNA methylation profiling of chronic lymphocytic leukemia allows identification of epigenetically repressed molecular pathways with clinical impact |
| Q39975102 | Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia. |
| Q30449815 | Heavy ions, radioprotectors and genomic instability: implications for human space exploration |
| Q37627410 | Impact of aberrant DNA methylation patterns including CYP1B1 methylation in adolescents and young adults with acute lymphocytic leukemia |
| Q33409828 | Imprinted CDKN1C is a tumor suppressor in rhabdoid tumor and activated by restoration of SMARCB1 and histone deacetylase inhibitors |
| Q34507207 | Imprinting disruption of the CDKN1C/KCNQ1OT1 domain: the molecular mechanisms causing Beckwith-Wiedemann syndrome and cancer. |
| Q35571293 | Inhibitors of DNA methylation in the treatment of hematological malignancies and MDS. |
| Q81632645 | Methylation of p16(INK4A) and p57(KIP2) are involved in the development and progression of gastric MALT lymphomas |
| Q54759183 | Methylation, aging, and pediatric acute lymphocytic leukemia. |
| Q36001860 | Molecular marks for epigenetic identification of developmental and cancer stem cells |
| Q36583644 | Mutation of epigenetic regulators TET2 and MLL3 in patients with HTLV-I-induced acute adult T-cell leukemia |
| Q37310211 | Nucleoside analogs: molecular mechanisms signaling cell death. |
| Q35848726 | Phase 1/2 study of the combination of 5-aza-2'-deoxycytidine with valproic acid in patients with leukemia |
| Q36871702 | Poor prognosis in acute lymphoblastic leukemia may relate to promoter hypermethylation of cancer-related genes |
| Q35571288 | Profiling aberrant DNA methylation in hematologic neoplasms: a view from the tip of the iceberg |
| Q38294517 | Promoter analysis of epigenetically controlled genes in bladder cancer. |
| Q34327110 | Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia. |
| Q52691327 | RNA-Seq reveals the existence of a CDKN1C-E2F1-TP53 axis that is altered in human T-cell lymphoblastic lymphomas. |
| Q38835910 | Rapamycin restores p14, p15 and p57 expression and inhibits the mTOR/p70S6K pathway in acute lymphoblastic leukemia cells |
| Q37116917 | Residual DNA methylation at remission is prognostic in adult Philadelphia chromosome-negative acute lymphocytic leukemia |
| Q37810062 | Role of epigenetic therapy in myelodysplastic syndrome |
| Q38002122 | Role of p53 family members p73 and p63 in human hematological malignancies |
| Q34345218 | Safety and clinical activity of 5-aza-2'-deoxycytidine (decitabine) with or without Hyper-CVAD in relapsed/refractory acute lymphocytic leukaemia |
| Q42850721 | Some facts and thoughts: p73 as a tumor suppressor gene in the network of tumor suppressors |
| Q37901485 | Targeting epigenetics through histone deacetylase inhibitors in acute lymphoblastic leukemia |
| Q53556908 | The cell cycle inhibitor p57(Kip2) promotes cell death via the mitochondrial apoptotic pathway. |
| Q36247797 | Transcriptional upregulation of p57 (Kip2) by the cyclin-dependent kinase inhibitor BMS-387032 is E2F dependent and serves as a negative feedback loop limiting cytotoxicity |
| Q37590120 | Transforming growth factor beta-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation. |
| Q28081287 | Tumor Suppressor Inactivation in the Pathogenesis of Adult T-Cell Leukemia |
| Q53145261 | mRNA expression and promoter DNA methylation status of CDKi p21 and p57 genes in ex vivo expanded CD34 (+) cells following co-culture with mesenchymal stromal cells and growth factors. |
| Q89967527 | miR-221-3p Delivered by BMMSC-Derived Microvesicles Promotes the Development of Acute Myelocytic Leukemia |
| Q35326348 | p53 Family: Role of Protein Isoforms in Human Cancer |